Other

2020

AKC CHF 02800, $6,000. Defining the Effects of Genotype, Breed and Age on the Risk of Developing Canine Degenerative Myelopathy and Investigating the Molecular Mechanisms Underlying That Risk. Dr. Gary Johnson, University of Missouri.

2018

AKC CHF 02210. $6,000. Gene Therapeutic For Degenerative Myelopathy AAV9 Mediated SOD1 Downregulation. Dr. Kathrin Meyer, The Research Institute at Nationwide Children’s Hospital.
AKC CHF 02328-A, $5,000. Harmonization of Genetic Testing For Dogs. Dr. Brenda Bonnett, International Partnership For Dogs.
AKC CHF 02275, $10,000. Disease Risks Associated With Spay and Neuter: A Blood Specific, Gender Specific Perspective. Dr. Benjamin Hart, University of California Davis.

2017

$50,000 AKC/CHF Tick Borne Disease Initiative – Matched by the American Kennel Club, Inc.

2016

02264A: Role of E.Coli Biofilm in canine pyometria – $4000
02107: Landmark Clinical Trial to Establish Evidence Based Medicine based on the use of Regenerative Medicine to treat tendon injury in dogs – $5000
02210: Gene Therapy for Canine Degenerative Myelopathy – $5000
02226: Pilot Clinical Trial-Efficacy of Mesenchymal stem cells if the over-expression IL-10 to treat Osteoarthritis – $1000
02165: ID Biomarker and treatment Targets for Degenerative Myelopathy- the Search for the Cure – $2000
02237A: Capturing Tumor Cells in Canine Blood – $1000
02267A: Epidemiological Study of Brucella canis – $1000
02138: Accurate Hypothyroid Test – $2000
02234: A Novel Approach to preventing canine Hemangiosarcoma – $2000

2015

AKC CHF (02138): Development of Accurate Diagnostic Tests for Canine Hypothyroidism – $2,000
AKC CHF (01822): Beyond the Genome: The Intersection of Genes and the Environment in Canine Cancer – $1,000
AKC CHF (01849): Filling the Gaps in the Canine Genome – $3,000
AKC CHF (01840): Health Implications of Early Spay/Neuter on Canine Health – $3,500
AKC CHF (02118-A): Targeting the Mechanism of Bacterial Adherence during Pyometra to Develop an Effective, Non-Invasive Treatment for Disease – $2,000
AKC CHF (02107): Landmark Clinical Trial to Establish the Evidence-Based Use of Regenerative Medicine to Treat Tendon Injury in Dogs – $1,500
AKC CHF (01985): Defining Novel Drug Targets to Treat Chronic and Neuropathic Pain in the Dog – $2,000

2014

Defining the Genetic Basis of Inflammatory Bowel Disease (AKC CHF) $3,000
Profiling the Metabolic and Lipid Imbalances that are Causitive of Gallbladder Disease in Dogs (AKC CHF) $4,000
Mapping of Genetic Risk Factors for Canine Hip Dysplasia (AKC CHF) $5,000
Defining Novel Drug Targets to Treat Chronic and Neuropathic Pain in the Dog (AKC CHF) $5,000
WSU Grant – To Develop a Cell Culture Based Method of Screening Drugs to Determine Whether or Not They are P-go Substrates $19,726

2013

Identification and Validation of the Genes that Define Abnormal Development of the Kidney in Dogs (AKC CHF) $7,500
Treatment of Urinary Incontinence with Multipotent Muscle Cells (AKC CHF) $5,000
Filling the Gaps in the Canine Genome (AKC CHF) $3,000
DLA Research Grant: Investigation of Diversity at the Dog Leukocyte Antigen Class II Loci in American and International Collies $10,930

2012

Sequencing and Functional Analysis of the Canine Y Chromosomes (AKC CHF) $2,500
Urinary Incontinence Study: Extension of Grant too Add More Dogs to the Study $3,600
Polyneuopathy Study – The Use of Skin Punch Biopsy to Diagnose Polyneuropathy $5,340
Plasma Cortisol Concentrations in Dogs with Pituitary Dependent Hyper-adrenalcorticism & Atypical Cushing Syndrome (AKC CHF) $1,000

2011

$14,820 GnRH Immunization for the Treatment of Urinary Incontinence in Spayed Bitches Researcher: Dr Michelle Kutzler, DVM, PhD, DACT and Dr Timothy Hazzard, DVM Ph Institution: Oregon State University

2010

$10,000 Identification of a VWD (von WIllebrands Disease) causal mutation & development of a direct DNA test – Dr. George Brewer & Robert H. Loechel, MS.

2008

$2,500 AKC/CHF Grant #1142 – Dr. Amara H. Estrada, DVM, DACVIM – Univ of FL – Cutting Balloon Valvuloplasty for Dogs with Subaortic Stenosis
Amount: $38,433.60

2006

$10,000 Mandi J. Lopez, DVM, PhD, Louisiana State University • Quantification of osteoprotegerin (OPG) and receptor activator of nuclear factor kappa B ligand (Ranel) expression in normal and orteoarthritic canine coxofemoral articular cartilage.

2004

$20,000 Inclusion of Collies in the Canine Phenome Project, University of Missouri
$10,000 With AKC CHF, Fred Hutchinson Cancer Research Center • Development of a New Resource for Positional Cloning of Hip Dysplasia Genes: A High Density SNP Map of Canine Chromosome One
$10,000 With AKC CHF, University of Alaska, Fairbanks • Genetic Determinants of Hypothyroid Disease in Dogs

2003

$2,600 With AKC/CHF Recombinant Thyrotropin (TSH) Standard — Immunoassay with Improved Sensitivity
$2,000 With AKC CHF • Role of Circulating Endothelial Progenitor Cells

2001

$2,750 With AKC CHF • Mechanisms for Hypercoagulatibility in Immune Mediated Hemolytic Anemia and Early Disseminated Intravascular Coagulation (2 yr. study – $1,375 per year)

1995